Cost-efficacy analysis of two different formulations of glipizide in the treatment of type 2 diabetes
ZHANG Jun-dong1, XU Zheng2
Cost-efficacy analysis of two different formulations of glipizide in the treatment of type 2 diabetes
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |